Bank of New York Mellon
EWTX icon

Bank of New York Mellon’s Edgewise Therapeutics EWTX Stock Holding History

Bank of New York Mellon’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.63M Buy
212,347
+19,913
+10% +$686K ﹤0.01% 2107
2026
Q1 		$6.06M Sell
192,434
-6,180
-3% -$178K ﹤0.01% 2206
2025
Q4 		$4.93M Sell
198,614
-5,628
-3% -$113K ﹤0.01% 2331
2025
Q3 		$3.31M Sell
204,242
-8,616
-4% -$122K ﹤0.01% 2551
2025
Q2 		$2.79M Buy
212,858
+2,123
+1% +$30.6K ﹤0.01% 2585
2025
Q1 		$4.64M Sell
210,735
-321
-0.2% -$8.42K ﹤0.01% 2262
2024
Q4 		$5.64M Buy
211,056
+284
+0.1% +$9.04K ﹤0.01% 2231
2024
Q3 		$5.63M Sell
210,772
-57,940
-22% -$1.15M ﹤0.01% 2238
2024
Q2 		$4.84M Buy
268,712
+56,447
+27% +$985K ﹤0.01% 2362
2024
Q1 		$3.87M Buy
212,265
+66,095
+45% +$1.05M ﹤0.01% 2439
2023
Q4 		$1.6M Sell
146,170
-114
-0.1% -$800 ﹤0.01% 2946
2023
Q3 		$838K Sell
146,284
-2,633
-2% -$17.9K ﹤0.01% 3262
2023
Q2 		$1.15M Buy
148,917
+25,037
+20% +$211K ﹤0.01% 3117
2023
Q1 		$826K Sell
123,880
-3,815
-3% -$35.4K ﹤0.01% 3219
2022
Q4 		$1.14M Buy
127,695
+31,834
+33% +$298K ﹤0.01% 3132
2022
Q3 		$943K Sell
95,861
-93,378
-49% -$944K ﹤0.01% 3232
2022
Q2 		$1.51M Sell
189,239
-23,648
-11% -$179K ﹤0.01% 2990
2022
Q1 		$2.07M Sell
212,887
-1,626
-0.8% -$20.9K ﹤0.01% 2916
2021
Q4 		$3.28M Buy
214,513
+179,099
+506% +$3.22M ﹤0.01% 2694
2021
Q3 		$588K Buy
35,414
+6,941
+24% +$126K ﹤0.01% 3716
2021
Q2 		$607K Buy
+28,473
New +$778K ﹤0.01% 3685

Other funds holding EWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Bank of New York Mellon's EWTX Position: Q2 2026 in Review

Bank of New York Mellon increased its Edgewise Therapeutics (EWTX) stake by 10% in Q2 2026, buying an estimated $686K and bringing the position to 212,347 shares worth $8.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2107.

Bank of New York Mellon first reported a position in EWTX in Q2 2021 and has held it in 21 quarters since. 88 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Bank of New York Mellon held 212,347 shares of Edgewise Therapeutics worth $8.63M as of Q2 2026.
  • Bank of New York Mellon bought 19,913 Edgewise Therapeutics shares in Q2 2026, an estimated $686K.
  • Edgewise Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2107 holding.
  • Bank of New York Mellon first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 88 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.